Used primarily in research settings as a potent histamine H3 receptor antagonist, this compound is valuable for studying neurological pathways related to wakefulness, cognition, and attention. It has shown potential in enhancing neurotransmitter release, such as dopamine, norepinephrine, and acetylcholine, making it a candidate for investigating treatments for disorders like narcolepsy, ADHD, and Alzheimer’s disease. Its ability to promote alertness and cognitive performance in preclinical models supports its role in central nervous system drug development. However, it remains an experimental tool and is not approved for clinical use.